MAOBMonoamine Oxidase Type B (Parkinson's disease medication)
MAOBMaster of Arts in Organizational Behavior (various schools)
References in periodicals archive ?
MAOB (monoamine oxidase type B) inhibitors reduce the breakdown of dopamine in the brain and COMT (catechol-O-methyltransferase) inhibitors reduce the brain's ability to breakdown levodopa.
Patients with early Parkinson's are prescribed levodopa, dopamine agonists or MAOB inhibitors, while those with later Parkinson's who have motor complications that are uncontrolled by their existing drug therapy will be given one of the other drugs as follow-on treatment.